STATinMED Research announced Wednesday, Sept. 25, the appointment of Dr. Nora Janjan as the organization’s chief medical officer.
According to a press release, Janjan “will play as a key role in STATinMED’s expansion within oncology and cardiology and will contribute her real-world clinical and HEOR expertise to research projects in all medical disciplines.”
“While our uniquely comprehensive access to multiple data sources, proven analytical expertise and proprietary algorithms are already well-known throughout the industry, Dr. Janjan will enhance value in all STATinMED’s service offerings through her clinical, academic, public policy and HEOR expertise,” STATinMED President Doug Brenner said in a statement. “Already working on the cutting edge of analytics, Dr. Janjan’s guidance adds an exciting new level of depth and versatility to our data team.”
To learn more about STATinMED, click here.